USSTOCK.TODAY
After-Market
Log in Sign up

Royalty Pharma: A Dividend-Yield Stock for Investors Without Pharmaceutical Expertise

The Motley Fool +1 ·

RPRX Royalty Pharma plc
$63.75 +2.57%
View chart & analysis →
  1. 1Royalty Pharma recorded a market capitalization of $27.67 billion.
  2. 2Royalty Pharma currently shows a yield of approximately 1.5%.
  3. 3Royalty Pharma provides upfront payments to pharmaceutical companies and gains the right to receive future royalties from approved drugs.

So what's the key point?

Royalty Pharma provides money to pharmaceutical companies in advance and receives a share of future drug sales profits. The yield is approximately 1.5%.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Ingredion's Q2 adjusted operating profit falls 5%… maintains EPS guidance GuruFocus.com +1 · Aug 5AstraZeneca receives accelerated FDA approval for rare disease treatment Ultomiris Pharmaceutical Technology +2 · 3h agoSchwab U.S. Dividend Equity ETF continues dividend growth despite recent decline in returns The Motley Fool +1 · 3h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news